Abstract:BACKGROUND Within a pharmacoepidemiologic study, characteristics of patients with schizophrenia switched from first- to second-generation antipsychotics (FGAs and SGAs, respectively) or to antipsychotic polypharmacy were compared with those of patients maintained on treatment with FGAs. The primary aim was to assess factors associated with antipsychotic switching and to compare disease course with regard to mental state and social functioning. METHOD Adult inpatients with an ICD-10 diagnosis of schizophrenia or schizoaffective disorder were assessed in 7 psychiatric hospitals. Data were collected between 2001 and 2002. For those patients (N = 847) with an antipsychotic prescription at discharge, t tests and covariance and logistic regression analyses were used to evaluate the relationship between demographic and clinical characteristics and antipsychotic switching. RESULTS Patients switched from FGAs to SGAs had fewer previous psychiatric admissions, a shorter illness duration, fewer substance disorders, and a higher probability of working in a competitive setting but more pronounced symptoms than those maintained on treatment with FGAs. Mental state and social functioning after case-mix adjustment were more favorable in the group switched to SGA monotherapy but not in those patients administered FGAs and SGAs concurrently at discharge. Logistic regression controlling for demographic and clinical variables revealed that a short disease duration (p <.05), fewer previous psychiatric hospitalizations (p <.01), voluntary admission (p <.05), and pronounced thought disorder (p <.05) were significantly associated with switching from FGAs to SGAs. Hospital differences were also observed. CONCLUSION Remaining on FGAs or switching to SGAs in schizophrenia care depends strongly on institutional practices in addition to the previous disease course and health care utilization.

Polarimetric radar measurements of a forested area near Mt. Shasta

Magnetite Fe3O4 Nanoparticles and Hematite Α-Fe2o3 Uniform Oblique Hexagonal Microdisks, Drum-Like Particles and Spindles and Their Magnetic Properties

Switching antipsychotics in inpatient schizophrenia care: predictors and outcomes.

Energetic Electron-Assisted Synthesis of Tailored Magnetite (Fe3O4) and Maghemite (γ−Fe2O3) Nanoparticles: Structure and Magnetic Properties

Synthesis of Nanometer-Size Maghemite Particles from Magnetite

Controlled Synthesis of Magnetic Iron Oxide Nanoparticles: Magnetite or Maghemite?

Effective Approach for the Synthesis of Monodisperse Magnetic Nanocrystals and M-Fe3O4 (M = Ag, Au, Pt, Pd) Heterostructures

Synthesis, Surface Modification and Characterization of Magnetic Fe3O4@SiO2 Core-Shell Nanoparticles

Standardizing Size- and Shape-Controlled Synthesis of Monodisperse Magnetite (Fe3O4) Nanocrystals by Identifying and Exploiting Effects of Organic Impurities

Size-controlled synthesis of monodisperse superparamagnetic iron oxide nanoparticles

Size- and Shape-Controlled Synthesis and Properties of Magnetic-Plasmonic Core-Shell Nanoparticles.

Chemical synthesis and magnetic properties of monodisperse cobalt ferrite nanoparticles

Preparation of Monodispersed Hybrid Nanospheres with High Magnetite Content from Uniform Fe3O4 Clusters

Magnetic and Electronic Properties of Anisotropic Magnetite Nanoparticles

Mössbauer and Magnetic Studies of Surfactant Mediated Ca-Mg Doped Ferrihydrite Nanoparticles

Synthesis and Magnetic Properties of Uniform Hematite Nanocubes

Shape Tuning of Magnetite Nanoparticles Obtained by Hydrothermal Synthesis: Effect of Temperature

Plant protein-mediated size-controlled synthesis of magnetite nanoparticles – Studies on optical properties

Influence of Morphology and Surface Exchange Reaction on Magnetic Properties of Monodisperse Magnetite Nanoparticles

Low-Temperature Synthesis of Superparamagnetic Nanocomposite Particles Composed of Platinum and Maghemite

Facile Synthesis of Size-Controllable Monodispersed Ferrite Nanospheres